Skip to main content
. 2021 Feb 23;10(5):e018789. doi: 10.1161/JAHA.120.018789

Table 2.

Presence of CHIP in Relation to Individual Lifestyle Factors and Healthy Lifestyle Score (n=8709)

Variable CHIP (Yes/No) Minimally Adjusted Model* Fully Adjusted Model
OR (95% CI) P Value OR (95% CI) P Value
Healthy lifestyle score (range)
Category 1 (0–1) 274/3257 Referent 0.48 Referent 0.35
Category 2 (2) 271/2651 1.11 (0.93–1.32) 1.13 (0.93–1.37)
Category 3 (3–4) 201/2055 1.01 (0.83–1.23) 0.99 (0.80–1.23)
P trend 0.82 0.95
Healthy lifestyle score, continuous 1.00 (0.92–1.08) 0.96 0.98 (0.90–1.08) 0.72
AHEI (range)
Quintile 1 (18–42.3) 133/1606 Referent 0.37 Referent 0.22
Quintile 2 (42.3–48.1) 138/1604 0.99 (0.77–1.27) 1.05 (0.80–1.37)
Quintile 3 (48.1–53.4) 137/1605 0.96 (0.74–1.23) 0.93 (0.71–1.23)
Quintile 4 (53.4–59.9) 170/1573 1.17 (0.92–1.49) 1.24 (0.96–1.61)
Quintile 5 (60–91) 168/1575 1.12 (0.88–1.43) 1.13 (0.86–1.48)
P trend 0.14 0.16
AHEI, continuous 1.00 (1.00–1.01) 0.20 1.01 (1.00–1.01) 0.22
Physical activity
Inactive 306/3473 Referent 0.51 Referent 0.71
Insufficiently active 233/2363 1.11 (0.93–1.33) 1.08 (0.89–1.31)
Active 207/2127 1.07 (0.89–1.29) 1.03 (0.84–1.26)
P trend 0.42 0.73
MET h/wk, continuous 1.00 (1.00–1.01) 0.62 1.00 (0.99–1.01) 0.87
BMI
Obese (BMI >30 kg/m2) 271/2794 Referent 0.0246 Referent 0.0062
Overweight (25 kg/m2≤BMI≤30 kg/m2) 271/2815 0.89 (0.74–1.06) 0.83 (0.68–1.01)
Normal (18.5 kg/m2≤BMI≤25 kg/m2) 204/2354 0.76 (0.63–0.93) 0.71 (0.57–0.88)
P trend 0.0065 0.0015
BMI, continuous 1.02 (1.00–1.03) 0.0148 1.02 (1.01–1.04) 0.0028
Smoking
Current smoker 48/594 Referent 0.0205 Referent 0.0336
Past smoker 339/3238 1.08 (0.79–1.49) 1.01 (0.72–1.41)
Never smoker 359/4131 0.87 (0.63–1.19) 0.81 (0.58–1.13)
P trend 0.0199 0.0168
Pack‐year of smoking, continuous 1.00 (1.00–1.01) 0.0094 1.00 (1.00–1.01) 0.0103

AHEI indicates Alternate Healthy Eating Index‐2010; BMI, body mass index; CHIP, clonal hematopoiesis of indeterminate potential; MET, metabolic equivalent task; and OR, odds ratio.

*

Model adjusted for age at CHIP and race/ethnicity, stratified by case type (stroke, venous thromboembolism, and controls).

Model adjusted for age at CHIP, race/ethnicity, education, income, marital status, use of cholesterol‐lowering medication, history of treated diabetes mellitus, hypertension, family history of cancer and hormone therapy use, and WHI (Women's Health Initiative) trial participation, stratified by case type (stroke, venous thromboembolism, and controls).

P value for trend test was obtained from the regression model by fitting the categorical variable as a continuous variable to evaluate a dose‐response relationship.